secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-11-10T21:05:21+00:00
Accession:  0001213900-26-118006
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4.1-flash:cloud@v2

Tempest stockholders approve Lincoln Park 20% issuance and PIPE warrant proposals at 2026 annual meeting
--------------------------------------------------------------------------------

- Stockholders approved issuance of 20% or more of outstanding common stock under the Lincoln Park Capital Fund purchase agreement: 9,639,712 for, 490,295 against.
- PIPE proposal approved: 3,105,591 Series C and 3,105,591 Series D warrant shares, plus 217,391 placement agent warrants for H.C. Wainwright (SPA dated Sept 11, 2026).
- John David Yee re-elected Class II director (9,910,731 for, 235,236 withheld) and William Drake Richey (9,840,725 for, 305,242 withheld), terms running to the 2029 annual meeting.
- Ernst & Young LLP ratified as independent registered public accounting firm for fiscal year ending December 31, 2026: 10,111,485 for, 15,607 against, 18,875 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000121390026118006/0001213900-26-118006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000121390026118006/ea0311733-8k_tempest.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-118006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer